Completed PHASE3 INTERVENTIONAL 2-arm NCT00170690

Preference Study With Elderly Patients Recurrent Ovarian Cancer

Präferenz-Studie Bei älteren Patientinnen Mit Ovarialkarzinomrezidiv: Treosulfan Oral vs. intravenös

Sponsor: North Eastern German Society of Gynaecological Oncology

Interventions Treosulfan

Updated 6 times since 2017 Last updated: May 31, 2013 Started: Aug 31, 2004 Primary completion: Dec 31, 2011 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00170690, this PHASE3 trial focuses on Ovarian Cancer and remains completed. Sponsored by North Eastern German Society of Gynaecological Oncology, it has been updated 6 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2020 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2020 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

North Eastern German Society of Gynaecological Oncology

Data source: North Eastern German Society of Gynaecological Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany